Soleno Therapeutics, Inc. - Common Stock (SLNO)

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is the focus of IBN’s latest stock spotlight. The company’s shares have moved -1.14% on the day to $48.05.

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is the focus of IBN’s latest stock spotlight. The company’s shares have moved 2.83% on the day to $48.66.

Shares of Soleno Therapeutics, Inc. (NASDAQ: SLNO) traded at a new 52-week high today and are currently trading at $23.03. So far today, approximately 140.58k shares have been exchanged, as compared to an average 30-day volume of 383.77k shares.

Breakthrough Results from Study C602 Soleno Therapeutics, Inc. (NASDAQ: SLNO), a trailblazer in the biopharmaceutical industry, recently unveiled its promising

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is one today’s most active stocks by volume. So far today, approximately 21.3M shares of Soleno Therapeutics, Inc. have been exchanged, as compared to an average 30-day volume of 107.67k shares.

Shares of Soleno Therapeutics, Inc. (NASDAQ: SLNO) traded at a new 52-week high today and are currently trading at $22.92. So far today, approximately 20.61M shares have been exchanged, as compared to an average 30-day volume of 107.67k shares.

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is one of today’s top gainers. The company’s shares are currently up 16.86% on the day to $4.96.

These three penny (and nickel) stocks in the healthcare sector have a lot of potential for 2023, and definitely worth watching.